Detalhe da pesquisa
1.
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.
Am J Hematol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622840
2.
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma.
Future Oncol
; 19(1): 7-17, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779512
3.
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
Br J Haematol
; 199(3): 355-365, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111391
4.
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Blood
; 136(8): 936-945, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325490
5.
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy.
Am J Hematol
; 97(9): 1170-1177, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731911
6.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
7.
Current Controversies in the Management of Myeloma Bone Disease.
J Cell Physiol
; 231(11): 2374-9, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26910829
8.
Acute Kidney Injury in a Patient With Monoclonal Gammopathy.
Am J Kidney Dis
; 76(6): A10-A12, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222763
9.
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Blood Cancer J
; 14(1): 69, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649340
10.
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation.
EJHaem
; 4(3): 775-778, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601885
11.
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 10(11): e890-e901, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776872
12.
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Transplant Cell Ther
; 29(3): 174.e1-174.e10, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494017
13.
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial.
Lancet Haematol
; 10(10): e825-e837, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708911
14.
Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study.
JMIR Cancer
; 8(4): e39271, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480243
15.
Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience.
Clin Lymphoma Myeloma Leuk
; 22(2): 105-112, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686447
16.
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 40(25): 2901-2912, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34898239
17.
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.
Clin Lymphoma Myeloma Leuk
; 22(5): 297-304, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844892
18.
Pericardial Tamponade and Other Cardiac Complications in POEMS Syndrome.
JACC Case Rep
; 3(2): 286-290, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34317520
19.
High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250400
20.
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.
Leukemia
; 35(1): 18-30, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32778736